EMDB/PDB/SASBDBから引用されている文献のデータベース

キーワード
構造解析手法	All X線回折 NMR 電子顕微鏡小角散乱中性子線回折線維回折粉末回折赤外分光 EPR FRET 理論モデルハイブリッド
著者・登録者
ジャーナル
IF	>30 >20 >10 >5 all

タイトル	Fragment-Based Approach to the Development of an Orally Bioavailable Lactam Inhibitor of Lipoprotein-Associated Phospholipase A2 (Lp-PLA2).
ジャーナル・号・ページ	J. Med. Chem., Vol. 59, Page 10738-10749, Year 2016
掲載日	2016年9月29日 (構造データの登録日)
著者	Woolford, A.J. / Day, P.J. / Beneton, V. / Berdini, V. / Coyle, J.E. / Dudit, Y. / Grondin, P. / Huet, P. / Lee, L.Y. / Manas, E.S. ...Woolford, A.J. / Day, P.J. / Beneton, V. / Berdini, V. / Coyle, J.E. / Dudit, Y. / Grondin, P. / Huet, P. / Lee, L.Y. / Manas, E.S. / McMenamin, R.L. / Murray, C.W. / Page, L.W. / Patel, V.K. / Potvain, F. / Rich, S.J. / Sang, Y. / Somers, D.O. / Trottet, L. / Wan, Z. / Zhang, X.
リンク	J. Med. Chem. / PubMed:27933945
手法	X線回折
解像度	2.05 - 2.17 Å
構造データ	PDB-5lyy: Fragment-based inhibitors of Lipoprotein associated Phospholipase A2 手法: X-RAY DIFFRACTION / 解像度: 2.17 Å PDB-5lz2: Fragment-based inhibitors of Lipoprotein associated Phospholipase A2 手法: X-RAY DIFFRACTION / 解像度: 2.1 Å PDB-5lz4: Fragment-based inhibitors of Lipoprotein associated Phospholipase A2 手法: X-RAY DIFFRACTION / 解像度: 2.07 Å PDB-5lz5: Fragment-based inhibitors of Lipoprotein associated Phospholipase A2 手法: X-RAY DIFFRACTION / 解像度: 2.05 Å PDB-5lz7: Fragment-based inhibitors of Lipoprotein associated Phospholipase A2 手法: X-RAY DIFFRACTION / 解像度: 2.1 Å PDB-5lz8: Fragment-based inhibitors of Lipoprotein associated Phospholipase A2 手法: X-RAY DIFFRACTION / 解像度: 2.11 Å PDB-5lz9: Fragment-based inhibitors of Lipoprotein associated Phospholipase A2 手法: X-RAY DIFFRACTION / 解像度: 2.06 Å
化合物	ChemComp-7BJ: 3-[2-(4-fluoranylphenoxy)ethyl]-1,3-diazaspiro[4.5]decane-2,4-dione ChemComp-HOH: WATER ChemComp-NA: Unknown entry / ナトリウムカチオン ChemComp-CL: Unknown entry / クロリド ChemComp-7BX: 3-cyano-~{N}-cyclopropyl-benzenesulfonamide ChemComp-7BW: 5-[2-(4,4-dimethyl-2-oxidanylidene-pyrrolidin-1-yl)ethoxy]-2-fluoranyl-benzenecarbonitrile ChemComp-7K4: 2-fluoranyl-5-[2-[(4~{S})-4-methyl-2-oxidanylidene-4-phenyl-pyrrolidin-1-yl]ethoxy]benzenecarbonitrile ChemComp-7BK: 2-fluoranyl-5-[2-[(4~{R})-4-methyl-2-oxidanylidene-4-phenyl-pyrrolidin-1-yl]ethoxy]benzenecarbonitrile ChemComp-7BP: 5-[2-[(4~{S})-4-~{tert}-butyl-2-oxidanylidene-pyrrolidin-1-yl]ethoxy]-2-fluoranyl-benzenecarbonitrile ChemComp-7BR: 2-fluoranyl-5-[2-[(4~{S})-4-[4-methyl-1,1-bis(oxidanylidene)thian-4-yl]-2-oxidanylidene-pyrrolidin-1-yl]ethoxy]benzenecarbonitrile / 4-メチル-4-[(3S)-1-[2-(3-シアノ-4-フルオロフェノキシ)エチル]-5-オキソ-3α-ピロリジニル](以下略)
由来	homo sapiens (ヒト)
キーワード	HYDROLASE / Lp-PLA2 phospholipase / lipid metabolism / inhibitors / Lp-PLA2#4